EICHORCondition: Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage · Sponsor: Shenyang Northern Hospital
Current guidelines recommend that patients with ACS undergoing stent implantation might be offered extended DAPT treatment for up to 30 months if necessary. Therefore, we designed a prospective, multicenter, randomized, placebo-controlled trial among ACS patients with high-risk on ischemic and bleeding who received a new generation of DES and received 9 to 12 months of DAPT, and evaluated whether clopidogrel monotherapy reduce the risk of bleeding compared with clopidogrel plus ASA in the following 9 months and achieved non-inferior outcomes in preventing ischemic risk.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Anhui Provincial Hospital | Hefei, Anhui, China | — |
| The Seventh Medical Center of Pla General Hospital | Beijing, Beijing Municipality, China | — |
| Beijing Anzhen Hospital,Capital Medical University, word2 | Beijing, Beijing Municipality, China | — |
| Beijing Anzhen Hospital,Capital Medical University, word3 | Beijing, Beijing Municipality, China | — |
| PLA Rocket Force Characteristic Medical Center | Beijing, Beijing Municipality, China | — |
| Peking University International Hospital | Beijing, Beijing Municipality, China | — |
| Beijing Tsinghua Changgung Hospital | Beijing, Beijing Municipality, China | — |
| Xinqiao Hospital Army Medical University | Chongqing, Chongqing Municipality, China | — |
| Department of Cardiology, Daping Hospital, The Third Military Medical University | Chongqing, Chongqing Municipality, China | — |
| University-Town Hospital Of Chongqing Medical University | Chongqing, Chongqing Municipality, China | — |
| Fujian Medical University Union Hospital | Fuzhou, Fujian, China | — |
| Fujian Provincial Hospital | Fuzhou, Fujian, China | — |
+ 91 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03431142